LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 202 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $511,700 | -28.4% | 7,000 | -30.0% | 0.00% | 0.0% |
Q4 2023 | $714,200 | +67.9% | 10,000 | +40.8% | 0.00% | 0.0% |
Q3 2023 | $425,432 | -16.9% | 7,100 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $511,910 | +34.0% | 7,100 | +183.4% | 0.00% | – |
Q1 2021 | $382,000 | -92.8% | 2,505 | -93.6% | 0.00% | -100.0% |
Q4 2018 | $5,327,000 | +6.1% | 39,256 | +114.7% | 0.01% | +20.0% |
Q3 2018 | $5,019,000 | +56.0% | 18,285 | +17.8% | 0.01% | +66.7% |
Q2 2018 | $3,217,000 | -29.7% | 15,527 | -43.9% | 0.00% | -25.0% |
Q1 2018 | $4,575,000 | -13.2% | 27,702 | -28.0% | 0.00% | 0.0% |
Q4 2017 | $5,270,000 | -30.0% | 38,488 | -30.4% | 0.00% | -42.9% |
Q3 2017 | $7,531,000 | -9.4% | 55,317 | -19.2% | 0.01% | -12.5% |
Q2 2017 | $8,310,000 | +22.3% | 68,450 | +6.6% | 0.01% | +14.3% |
Q1 2017 | $6,796,000 | -14.0% | 64,214 | -17.4% | 0.01% | 0.0% |
Q4 2016 | $7,900,000 | -40.6% | 77,741 | -40.3% | 0.01% | -46.2% |
Q3 2016 | $13,290,000 | -12.9% | 130,218 | +1.7% | 0.01% | -18.8% |
Q2 2016 | $15,265,000 | -45.2% | 127,991 | -50.8% | 0.02% | -50.0% |
Q1 2016 | $27,845,000 | +1.6% | 260,016 | +2.9% | 0.03% | +3.2% |
Q4 2015 | $27,401,000 | +45.4% | 252,731 | +14.8% | 0.03% | +40.9% |
Q3 2015 | $18,848,000 | -29.4% | 220,060 | -16.8% | 0.02% | -24.1% |
Q2 2015 | $26,684,000 | -3.6% | 264,459 | -26.3% | 0.03% | -9.4% |
Q1 2015 | $27,678,000 | +26.9% | 358,938 | -12.4% | 0.03% | +33.3% |
Q4 2014 | $21,805,000 | +16.9% | 409,781 | +2.7% | 0.02% | +9.1% |
Q3 2014 | $18,648,000 | +7.7% | 399,083 | +43.6% | 0.02% | 0.0% |
Q2 2014 | $17,314,000 | -7.3% | 277,963 | -0.7% | 0.02% | 0.0% |
Q1 2014 | $18,684,000 | +47.6% | 279,831 | +16.2% | 0.02% | +37.5% |
Q4 2013 | $12,662,000 | +64.5% | 240,722 | +35.4% | 0.02% | +60.0% |
Q3 2013 | $7,695,000 | +21.0% | 177,806 | +4.5% | 0.01% | +11.1% |
Q2 2013 | $6,361,000 | – | 170,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |